Oxidative Stress and the Development of Osteoarthritis
氧化应激与骨关节炎的发展
基本信息
- 批准号:8437793
- 负责人:
- 金额:$ 39.46万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-09-30 至 2017-08-31
- 项目状态:已结题
- 来源:
- 关键词:1-Phosphatidylinositol 3-KinaseAffectAgeAgingAntioxidantsCartilageCell DeathCell SurvivalCellsChemicalsChondrocytesChronicCollagenCysteineDegenerative polyarthritisDevelopmentDiseaseDisease ProgressionElderlyEnzymesExhibitsGenerationsGenesHumanJointsLabelLinkMAPK8 geneMEKsMeasuresMechanicsMedial meniscus structureMeniscus structure of jointMitochondriaMitogen-Activated Protein KinasesModificationMusNormal CellOxidation-ReductionOxidative StressPathogenesisPathway interactionsPhosphorylationPlayPredispositionProcessProtein BiosynthesisProteinsProteoglycanProteomicsReactive Oxygen SpeciesRegulationRelative (related person)Respiratory ChainRoleSecond Messenger SystemsSerineSeveritiesSignal PathwaySignal TransductionSignaling ProteinSourceStress TestsSynovial CellTestingTissuesTransfectionTransgenic MiceWorkagedarticular cartilagebasecatalasecytokinedisabilityin vivoinhibitor/antagonistmitochondrial dysfunctionnovel strategiesoverexpressionoxidationp66(ShcA) proteinresponsesecond messengertert-Butylhydroperoxide
项目摘要
DESCRIPTION (provided by applicant): The long-term objective of this project is to determine the mechanisms by which oxidative stress contributes to the pathogenesis of osteoarthritis (OA) by focusing on mechanisms by which reactive oxygen species (ROS) alter cell signaling in the articular cartilage and meniscus. Oxidative stress results when levels of ROS exceed the anti-oxidant capacity of cells. Studies to date suggest that oxidative stress can contribute to fundamental processes found in OA, including excessive catabolic relative to anabolic activity and cell death, but the mechanisms responsible have not been defined. Mitochondria are an important source of intracellular ROS and our preliminary studies demonstrate that overexpression of the anti-oxidant enzyme catalase, targeted to the mitochondria in transgenic mice, reduces the severity of age-associated OA. We propose that in OA, pathological levels of ROS are generated by the mitochondria which, when combined with a deficient anti-oxidant capacity, results in excessive protein oxidation that shifts cell signaling to favor catabolic over
anabolic signaling and to promote cell death. Our studies will focus on mechanisms by which excessive levels of ROS disrupt the IRS-1-PI-3 kinase-Akt signaling pathway. Akt plays a central role in integrating anabolic and catabolic signaling as well as in promoting cell survival. We have found that in OA chondrocytes and in normal cells induced to exhibit oxidative stress, Akt activation is inhibited and this is associated with reduced matrix synthesis and increased susceptibility to cell death. We will pursue the following specific aims: 1) Determine the mechanism for inhibition of IRS-1-PI-3kinase-Akt signaling in chondrocytes during oxidative stress and test the hypothesis that excessive levels of ROS oxidize specific proteins that activate the MAP kinase pathway which inhibits Akt1 activation through inhibition of IRS-1-PI-3 kinase signaling and 2) Determine the effects of overexpression of catalase targeted to the mitochondria on the development of osteoarthritis in mice and test the hypothesis that overexpression of catalase will reduce OA severity. Effects on the signaling proteins discovered to be important in inhibiting Akt will be studied. The discoveries made by this work will be used to develop new therapies that would replace the untargeted general anti-oxidant approach with more a more targeted approach aimed at the specific pathways affected by oxidative stress and contributing to OA.
PUBLIC HEALTH RELEVANCE: Osteoarthritis is the most common cause of chronic disability in older adults but treatments to slow the progression of the disease are lacking. The results from this project will provide new information about basic mechanisms relevant to joint tissue breakdown in osteoarthritis. This information is needed in order to discover new targets for slowing or stopping the progression of the disease.
描述(由申请人提供):该项目的长期目的是确定氧化应激的机制,通过关注反应性氧(ROS)改变关节软骨和拟象中的细胞信号的机制,从而有助于骨关节炎(OA)的发病机理。 当ROS水平超过细胞的抗氧化能力时,氧化应激会产生。 迄今为止的研究表明,氧化应激可能有助于OA中发现的基本过程,包括相对于合成代谢活性和细胞死亡过多的分解代谢,但尚未定义造成的机制。 线粒体是细胞内ROS的重要来源,我们的初步研究表明,抗氧化酶催化酶的过表达靶向转基因小鼠的线粒体,可降低与年龄相关的OA的严重程度。 我们提出,在OA中,线粒体会产生ROS的病理水平,当与抗氧化能力不足相结合时,它会导致过量的蛋白质氧化,从而将细胞信号转移以有利于分解代谢而不是
合成代谢信号传导并促进细胞死亡。 我们的研究将重点放在过度水平的ROS破坏IRS-1-PI-3激酶-akt信号通路的机制上。 AKT在整合合成代谢和分解代谢的信号以及促进细胞存活方面起着核心作用。我们发现,在OA软骨细胞和诱导的正常细胞中,Akt激活受到抑制,这与基质合成的降低和对细胞死亡的敏感性增加有关。 We will pursue the following specific aims: 1) Determine the mechanism for inhibition of IRS-1-PI-3kinase-Akt signaling in chondrocytes during oxidative stress and test the hypothesis that excessive levels of ROS oxidize specific proteins that activate the MAP kinase pathway which inhibits Akt1 activation through inhibition of IRS-1-PI-3 kinase signaling and 2) Determine the effects of overexpression of catalase targeted关于小鼠骨关节炎发展的线粒体,并检验了过氧化氢酶过表达的假设将降低OA的严重程度。将研究发现对抑制AKT很重要的信号蛋白的影响。这项工作发现的发现将用于开发新的疗法,这些疗法将以更多针对受氧化应激影响的特定途径的更具针对性的方法来代替不受限制的一般抗氧化剂方法,并为OA贡献。
公共卫生相关性:骨关节炎是老年人慢性残疾的最常见原因,但缺乏疾病进展的治疗方法。该项目的结果将提供有关与骨关节炎关节组织分解有关的基本机制的新信息。为了发现减慢或阻止疾病进展的新目标,需要此信息。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RICHARD F LOESER其他文献
RICHARD F LOESER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RICHARD F LOESER', 18)}}的其他基金
Identifying novel osteoarthritis risk genes using GWAS, chondrocyte genomics, and genome editing
使用 GWAS、软骨细胞基因组学和基因组编辑识别新的骨关节炎风险基因
- 批准号:
10706477 - 财政年份:2022
- 资助金额:
$ 39.46万 - 项目类别:
Identifying novel osteoarthritis risk genes using GWAS, chondrocyte genomics, and genome editing
使用 GWAS、软骨细胞基因组学和基因组编辑识别新的骨关节炎风险基因
- 批准号:
10445527 - 财政年份:2022
- 资助金额:
$ 39.46万 - 项目类别:
The UNC Core Center for Clinical Research: Phenotyping and Precision Medicine Resource Core
北卡罗来纳大学临床研究核心中心:表型分析和精准医学资源核心
- 批准号:
10469655 - 财政年份:2019
- 资助金额:
$ 39.46万 - 项目类别:
The UNC Core Center for Clinical Research: Phenotyping and Precision Medicine Resource Core
北卡罗来纳大学临床研究核心中心:表型分析和精准医学资源核心
- 批准号:
10017049 - 财政年份:2019
- 资助金额:
$ 39.46万 - 项目类别:
Oxidative Stress and the Development of Osteoarthritis
氧化应激与骨关节炎的发展
- 批准号:
8840002 - 财政年份:2012
- 资助金额:
$ 39.46万 - 项目类别:
Oxidative Stress and the Development of Osteoarthritis
氧化应激与骨关节炎的发展
- 批准号:
8550762 - 财政年份:2012
- 资助金额:
$ 39.46万 - 项目类别:
Oxidative Stress and the Development of Osteoarthritis
氧化应激与骨关节炎的发展
- 批准号:
10659765 - 财政年份:2012
- 资助金额:
$ 39.46万 - 项目类别:
Oxidative Stress and the Development of Osteoarthritis
氧化应激与骨关节炎的发展
- 批准号:
10166738 - 财政年份:2012
- 资助金额:
$ 39.46万 - 项目类别:
相似国自然基金
多氯联苯与机体交互作用对生物学年龄的影响及在衰老中的作用机制
- 批准号:82373667
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
恒星模型中氧元素丰度的变化对大样本F、G、K矮星年龄测定的影响
- 批准号:12303035
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于年龄和空间的非随机混合对性传播感染影响的建模与研究
- 批准号:12301629
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
母传抗体水平和疫苗初种年龄对儿童麻疹特异性抗体动态变化的影响
- 批准号:82304205
- 批准年份:2023
- 资助金额:20 万元
- 项目类别:青年科学基金项目
中国东部地区大气颗粒物的年龄分布特征及其影响因素的模拟研究
- 批准号:42305193
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
相似海外基金
The role of TTC7A in apical lumen formation and polarized trafficking in the intestinal epithelium
TTC7A 在肠上皮顶腔形成和极化运输中的作用
- 批准号:
10464502 - 财政年份:2022
- 资助金额:
$ 39.46万 - 项目类别:
Molecular mechanisms of age-related lymphatic dysfunction
年龄相关淋巴功能障碍的分子机制
- 批准号:
10538995 - 财政年份:2022
- 资助金额:
$ 39.46万 - 项目类别:
From proteomics and genomics to therapeutics in systemic sclerosis interstitial lung disease
从蛋白质组学和基因组学到系统性硬化症间质性肺病的治疗
- 批准号:
10404144 - 财政年份:2022
- 资助金额:
$ 39.46万 - 项目类别:
E3 ubiquitin ligase RNF145 in airway smooth muscle functions and in asthma
E3 泛素连接酶 RNF145 在气道平滑肌功能和哮喘中的作用
- 批准号:
10522211 - 财政年份:2022
- 资助金额:
$ 39.46万 - 项目类别:
The Novel Mechanisms of Thrombosis Formation in Myeloproliferative Diseases
骨髓增生性疾病血栓形成的新机制
- 批准号:
10424485 - 财政年份:2020
- 资助金额:
$ 39.46万 - 项目类别: